Skip to main content

Table 1 Characteristics of Cancer Patients by FN Status and AOM

From: Comparing cancer incidence, stage at diagnosis and outcomes of First Nations and all other Manitobans: a retrospective analysis

Characteristic

First Nations

n = 1524 (4%)

AOM

n = 36,552 (96%)

p value

Age (years) mean ± SD

59.4 ± 14.4

67.4 ± 14.1

< 0.0001

Female Sex

845 (55.4%)

18,386 (50.3%)

< 0.0001

Regional Health Authority

  

< 0.0001

 Interlake-Eastern

338 (22.2%)

3838 (10.5%)

 

 Northern

535 (35.1%)

724 (2.0%)

 

 Southern Health

88 (5.8%)

4213 (11.5%)

 

 Prairie Mountain Health

168 (11.0%)

5873 (16.1%)

 

 Winnipeg

382 (25.1%)

21,728 (59.4%)

 

 Public Trustee

13 (0.9%)

176 (0.5%)

 

Average household income quintiles

< 0.0001

 Rural 1 (lowest rural)

587 (38.5%)

1876 (5.1%)

 

 Rural 2

252 (16.5%)

2957 (8.1%)

 

 Rural 3

86 (5.6%)

3009 (8.2%)

 

 Rural 4

126 (8.3%)

2755 (7.5%)

 

 Rural 5 (highest urban)

61 (4.0%)

2364 (6.5%)

 

 Urban 1 (lowest urban)

219 (14.4%)

4963 (13.6%)

 

 Urban 2

79 (5.2%)

4896 (13.4%)

 

 Urban 3

42 (2.8%)

4815 (13.2%)

 

 Urban 4

36 (2.4%)

4310 (11.8%)

 

 Urban 5 (highest urban)

15 (1.0%)

4103 (11.2%)

 

Charlson Comorbidity Index Score, mean ± SD

1.4 ± 1.3

1.0 ± 1.1

< 0.0001

 Myocardial infarction

46 (3%)

704 (1.9%)

 

 Congestive heart failure

106 (7.0%)

2200 (6.0%)

 

 Peripheral vascular disease

53 (3.5%)

1175 (3.2%)

 

 Cerebrovascular disease

62 (4.1%)

1469 (4.0%)

 

 Dementia

21 (1.4%)

1146 (3.1%)

 

 Chronic pulmonary disease

263 (17.3%)

5544 (15.2%)

 

 Connective tissue disease

56 (3.7%)

726 (2.0%)

 

 Peptic ulcer disease

73 (4.8%)

602 (1.6%)

 

 Mild liver disease

66 (4.3%)

678 (1.9%)

 

 Diabetes without complications

514 (33.7%)

5286 (14.5%)

 

 Diabetes with complications

105 (6.9%)

656 (1.8%)

 

 Paraplegia and hemiplegia

14 (0.9%)

214 (0.6%)

 

 Renal disease

83 (5.4%)

962 (2.6%)

 

 Cancer

519 (34.1%)

13,515 (37.0%)

 

 Moderate or severe liver disease

14 (0.9%)

153 (0.4%)

 

 Metastatic carcinoma

71 (4.7%)

1059 (2.9%)

 

 HIV/AIDS

8 (0.5%)

20 (0.1%)

Â